
Resorbable biomaterials, commonly used in implantable medical devices, have remained largely unchanged for decades. While effective, these materials often fall short in clinical performance, facing issues such as limited biocompatibility and suboptimal resorption rates. 4D introduces a new era of innovation with advanced biomaterials offering tailored formulations, predictable resorption through surface erosion, improved biocompatibility, and shape memory capabilities for smarter device designs. These materials are compatible with flexible manufacturing methods like 3D printing, casting, and coating, enabling diverse medical applications and aim to enhance patient outcomes and redefine possibilities in the medical device market.
- Investment status Current
- Invested 2021
- Category Deep Tech